Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 69,749 shares at $15.00 ($1.0M) on 2020-10-07, disclosed to the SEC on 2020-10-09.
Open-market sale of $1.0M GNMK by VP, Qual, Reg, & Clin Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2021-02-24 | $3K | — | Filing → |
| GNMK | SELL | 2021-02-22 | $6K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |